Class IIITerminatedD-0631-2021
Drug recall · June 23, 2021
Phytonadione Tablets 5 mg recall
Why: Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13
- Lots / codes
Lot: 38617 Exp. 10/2022
- Quantity
- 10 cartons
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Distributed in Los Angeles California
- Initiated
- June 9, 2021 · Voluntary: Firm initiated
- Classified
- June 16, 2021
- Reported
- June 23, 2021
- Ended
- June 2, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.